High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. (Q53187326)

12 May 2018

title

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. (English)

1 reference

12 May 2018

author name string

O P Erpolat

1

1 reference

12 May 2018

P U Gocun

2

1 reference

12 May 2018

M Akmansu

3

1 reference

12 May 2018

E Karakus

4

1 reference

12 May 2018

G Akyol

5

1 reference

12 May 2018

publication date

8 February 2012

1 reference

12 May 2018

Strahlentherapie und Onkologie

published in

1 reference

12 May 2018

volume

188

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

248-254

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00066-011-0042-7

exact match

0 references

cites work

Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Pattern of failure after helical tomotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Apoptosis-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Chromosomal passengers and the (aurora) ABCs of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Aurora-kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Nuclear or cytoplasmic expression of survivin: what is the significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin expression in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

The role of survivin for radiation oncology: moving beyond apoptosis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin inhibits anti-growth effect of p53 activated by aurora B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0042-7

Aurora kinase inhibitors in preclinical and clinical testing

21 January 2018

1 reference

12 December 2020

Survivin study: an update of "what is the next wave"?

1 reference

12 December 2020

Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications

1 reference

12 December 2020

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

12 December 2020

High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy

1 reference

12 December 2020

Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells

1 reference

12 December 2020

Mitotic kinase expression and colorectal cancer progression

1 reference

12 December 2020

A Planning Comparison of Dynamic IMRT for Different Collimator Leaf Thicknesses with Helical Tomotherapy and RapidArc for Prostate and Head and Neck Tumors

1 reference

12 December 2020

Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability.

1 reference

12 December 2020

10.1007/S00066-011-0042-7

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018